🇺🇸 Budesonide/formoterol 200/6 in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 22 April 2025 – 22 April 2026
Total reports: 5

Most-reported reactions

Drug Interaction — 1 report (20%)
Feeling Hot — 1 report (20%)
Headache — 1 report (20%)
Mental Disorder — 1 report (20%)
Withdrawal Syndrome — 1 report (20%)

Source database →

Other Respiratory/Pulmonology approved in United States

Frequently asked questions

Is Budesonide/formoterol 200/6 approved in United States?

Budesonide/formoterol 200/6 does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Budesonide/formoterol 200/6 in United States?

EMS is the originator. The local marketing authorisation holder may differ — check the official source linked above.